Liliana Ulianov

机构：Galderma (Switzerland) · ORCID：0009-0001-2897-6895

发表论文 28 篇 · 总被引 306 次 · h-index 7

代表论文

• Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials (2024 · The Lancet · 被引 145)
• Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study (2019 · European Journal of Dermatology · 被引 12)
• Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials (2023 · Dermatology and Therapy · 被引 9)
• A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4 and 12 Months of Age (2014 · The Pediatric Infectious Disease Journal · 被引 9)
• A Randomized, Controlled Trial to Assess the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Hib and Meningococcal Serogroup C Combination Vaccine Administered at 2, 3, 4 and 12–18 Months of Age (2013 · The Pediatric Infectious Disease Journal · 被引 8)
• Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study (2025 · Journal of the European Academy of Dermatology and Venereology · 被引 7)